CHE
Chemed Corp
NYSE: CHE · HEALTHCARE · MEDICAL CARE FACILITIES
$421.43
+2.14% today
Updated 2026-06-05
Market cap
$5.57B
P/E ratio
22.89
P/S ratio
2.19x
EPS (TTM)
$18.32
Dividend yield
0.55%
52W range
$365 – $560
Volume
0.2M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
4.0
Growth
C6.5
Quality
B7.5
Profitability
B+5.0
Valuation
C+3/9
Piotroski F-Score
Weak
5.7
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$446.50
+5.95%
12-Month target
$373.47
-11.38%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy3 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 5.69 — safe zone
+ ROE 30.64% — strong efficiency
+ Free cash flow $71.10M — positive
+ Debt/equity 0.28x — low leverage
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.13B | $2.26B | $2.43B | $2.53B | $2.54B |
| Net income | $249.62M | $272.51M | $302.00M | $265.24M | $66.30M |
| EPS | — | — | — | — | $18.32 |
| Free cash flow | $252.56M | $273.44M | $367.97M | $325.48M | $71.10M |
| Profit margin | 11.69% | 12.03% | 12.42% | 10.48% | 10.20% |
Peer comparison
Smart narrative
Chemed Corp trades at $421.43. representing a P/E of 22.89x trailing earnings. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 5.69, it sits in the safe zone. TTM revenue stands at $2.54B. with profit margins at 10.20%.
Frequently asked questions
What is Chemed Corp's stock price?
Chemed Corp (CHE) trades at $421.43, on a P/E of 22.9x and a P/S of 2.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Chemed Corp overvalued?
Chemed Corp carries a Smart Value Score of 51/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Chemed Corp (CHE)?
The 12-month analyst consensus target is $446.50, about 5.9% above the current $421.43. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Chemed Corp's revenue?
Chemed Corp's trailing twelve-month revenue is $2.54B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Chemed Corp's Altman Z-Score is 5.69, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.19x
ROE30.64%
Beta0.54
50D MA$415.81
200D MA$430.44
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—